Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-12

FDA Approved: BACLOFEN — Supplemental Application (Palmetto Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for baclofen from Palmetto Pharmaceuticals Inc., indicating an update to the drug's existing approval (such as labeling …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)